Dodávky léků – Léčivá látka rozanolixizumab – ATC L04AL02

TENDER DESCRIPTION

The subject of performance of the Public Contract are ongoing deliveries of a medicinal product containing the active substance rozanolixizumab – ATC L04AL02. dosage form 140MG/ML INJ SOL 1X2ML, unit of measure 1X2ML, quantity 600 dosage form 140MG/ML INJ SOL 1X3ML, unit of measure 1X3ML, quantity 100 The subject of performance of the Public Contract are ongoing deliveries of a medicinal product containing the active substance rozanolixizumab – ATC L04AL02. dosage form 140MG/ML INJ SOL 1X2ML, unit of measure 1X2ML, quantity 600 dosage form 140MG/ML INJ SOL 1X3ML, unit of measure 1X3ML, quantity 100

TENDER BRIEF

TENDER DOCUMENTS